Cite
Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades.
MLA
Imran, Mohd., et al. “Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades.” Pharmaceuticals (14248247), vol. 14, no. 8, Aug. 2021, p. 710. EBSCOhost, https://doi.org/10.3390/ph14080710.
APA
Imran, M., Asdaq, S. M. B., Khan, S. A., Unnikrishnan Meenakshi, D., Alamri, A. S., Alsanie, W. F., Alhomrani, M., Mohzari, Y., Alrashed, A., AlMotairi, M., Alkhaldi, E. H., Alorabi, A. K., Alshrari, A. S., Tauseef, M., Abida, Alaqel, S. I., Alam, O., & Bakht, M. A. (2021). Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades. Pharmaceuticals (14248247), 14(8), 710. https://doi.org/10.3390/ph14080710
Chicago
Imran, Mohd., Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Dhanalekshmi Unnikrishnan Meenakshi, Abdulhakeem S. Alamri, Walaa F. Alsanie, Majid Alhomrani, et al. 2021. “Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades.” Pharmaceuticals (14248247) 14 (8): 710. doi:10.3390/ph14080710.